Skip to content

Stroke Observatory of Caen-Normandie Metropole

Stroke Observatory of Caen-Normandie Metropole

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03684226
Acronym
NORMANDYSTROKE
Enrollment
2400
Registered
2018-09-25
Start date
2017-05-17
Completion date
2020-05-17
Last updated
2019-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

Stroke Observatory of Caen-Normandy Metropole provides epidemiological data in prospective collection. The primary objective is to determinate incidence of Stroke in this area. Several data sources will be crossed to allow an exhaustive identification of the cases. No intervention will be carried. The data collected will correspond to those obtained in current practice. The number of participants is estimated at 800 per year. This Observatory aims to become a qualified population register after three years, according to requirement of the french registry evaluation committee.

Detailed description

Stroke is the second leading cause of death (the first in women in industrialized countries), the second cause of dementia and the third leading cause of disability. For a middle-aged person, the risk of developing a stroke is 1/5 in women and 1/6 in men over a lifetime. Moreover, stroke is a disease that can be considered chronic. Indeed, in France, the survival rate one month after a stroke is 80-90%. However, at least 50% of survivors retain a severe disability and almost all require long-term care. The medico-economic impact of stroke is therefore important in both the initial and chronic phases. Nevertheless, none of the French stroke registries consider the burden of post-stroke disability. In addition, there is limited data available on the impact of geographic disparities on the prognosis of stroke. Population studies are essential to accurately identify the incidence and burden of stroke, thereby supporting public health policy, guiding the allocation of resources, and evaluating the effectiveness of preventive strategies for a population. This is why we propose to create a Norman Observatory of Stroke. It will include an urban and rural population and will aim to become a population register.

Interventions

None listed

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Days to No maximum
Healthy volunteers
No

Inclusion criteria

* Any types of strokes (initial, recidivism) * Place of residence in Caen-Normandie Metropole * Age higher than 30 days (exclusion of perinatal stroke)

Exclusion criteria

* None, unless patient opposition

Design outcomes

Primary

MeasureTime frameDescription
Stroke incidence in Caen-Normandy Metropole15 may 2017 to 15 may 2020To determinate the incidence of stroke in Caen-Normandy Metropole
Stroke acute mortality in Caen-Normandy Metropole15 may 2017 to 15 may 2020To determinate the incidence of Stroke acute mortality

Countries

France

Contacts

Primary ContactAudrey BARBEDETTE, phD
audrey.barbedette@unicaen.fr023-106-3183
Backup ContactSophie BUTT, CRA
sophie.butt@unicaen.fr023-106-3183

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026